logo

SICHUAN HONGRI PHARMA-TECH CO., LTD

Sales & Support
Request A Quote - Email
Select Language
Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsImpurities(Standards)

95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3

95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3

95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3
95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3

Large Image :  95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 Get Best Price

Product Details:
Place of Origin: CHINA
Brand Name: Enlai Biotech
Certification: ISO 9001 COA HPLC NMR
Payment & Shipping Terms:
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Inside: double PE bag Outside: paper drum
Delivery Time: In Stock
Payment Terms: T/T
Supply Ability: 100 kilograms per month
Detailed Product Description
Product Name: EnzalutamideImpurity14 CAS No: 749927-69-3
M.W: 232.05 MF: C8H7BrFNO
Appearance: White Powder Purity: 95+
EINECS No: - Storage: 5-25°C

 

Product Description

 

White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 Purity 95+

 

Name: EnzalutamideImpurity14

CAS NO749927-69-3

M.W: 232.05

Appearance: White Powder

Purity: 95+   

SynonymsEnzalutamideEPImpurityB;EnzalutamideImpurity14;N-METHYL4-BROMO-2-FLUORO;

 

Application

 

Drug production: During the production of Enzalutamide, manufacturers need to closely monitor potential impurities, including Enzalutamide Impurity 14. Through strict quality control measures, the purity and safety of the final product can be ensured.

Quality control: Pharmaceutical companies must follow strict quality standards, including those set by the International Conference on Harmonization (ICH). These standards require detailed analysis and limits on impurities in drugs to ensure patient safety.

 

Regulatory compliance: When submitting new drug applications or updating existing drug information to regulatory agencies (such as the US Food and Drug Administration FDA or the European Medicines Agency EMA), manufacturers must provide detailed data on drug impurities, including Enzalutamide Impurity 14.

 

Research and development: When developing new synthetic routes or optimizing existing drug production processes, researchers need to evaluate the impact of different impurities on drug performance. This research helps to better understand how to control and minimize impurity formation.

 

Safety assessment: Before a drug enters the market, extensive safety assessments are conducted, including evaluating the potential impact of impurities such as Enzalutamide Impurity 14 on patient health.

 

Package

 

 95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 0     95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 1 

95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 295+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 3

Transportation

 

Small package(1g, 25g, 1Kg, 25Kg) can be shipped by Express. (DHL, FedEx, EMS, etc.)
Large package(100kg and more than100Kg) can be transported by Air or Sea.

All transportation is in accordance with the customer's needs.

 

Company Profile

 

95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 495+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 5

95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 695+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 7

95+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 895+ White Powder EnzalutamideImpurity14 CAS NO. 749927-69-3 9

Contact Details
SICHUAN HONGRI PAHRM-TECH CO., LTD

Contact Person: admin

Send your inquiry directly to us